European Journal of Medicinal Chemistry
229
113998
no
2022-02-05
SCI
10.1016/j.ejmech.2021.113998
6.7
Pre One:Advances in research on 3C-like protease (3CLpro) inhibitors against SARS-CoV-2 since 2020
Next One:Advances of biphenyl small-molecule inhibitors targeting PD-1/PD-L1 interaction in cancer immunotherapy
Click :
The Last Update Time : ..